Inventiva S.A. (LON:0RNK)
London · Delayed Price · Currency is GBP · Price in EUR 2.880
0.00 (0.00%)
At close: Aug 7, 2025
Inventiva Market Cap
Inventiva has a market cap or net worth of 346.14 million as of August 8, 2025. Its market cap has increased by 257.70% in one year.
Market Cap
346.14M
Enterprise Value
419.26M
Revenue
11.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.88
Market Cap Chart
Since February 15, 2017, Inventiva's market cap has increased from 114.33M to 346.14M, an increase of 202.74%. That is a compound annual growth rate of 13.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 346.99M | 101.20% |
| Dec 31, 2024 | 172.46M | -6.03% |
| Dec 29, 2023 | 183.53M | 9.78% |
| Dec 30, 2022 | 167.18M | -58.50% |
| Dec 31, 2021 | 402.89M | -0.03% |
| Dec 31, 2020 | 403.00M | 382.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 169.80B |
| GSK plc | 55.78B |
| Haleon | 31.69B |
| Smith & Nephew | 11.76B |
| ConvaTec Group | 4.72B |
| Hikma Pharmaceuticals | 3.86B |
| HUTCHMED (China) | 2.11B |
| Oxford Nanopore Technologies | 2.04B |